ZURICH (Reuters) – Roche said on Friday that its controlling family will be exempt from having to make an offer to other shareholders after the drugmaker’s $20.7 billion deal to buy back Novartis’s nearly one third voting stake.
The pool of family shareholders, who previously owned 45.01% of the voting rights in Roche, were given the exemption by the Swiss takeover board, the company said. The decision was confirmed on the takeover board’s website.
In Switzerland a mandatory offer obligation is normally triggered whenever a shareholder or group of shareholders directly or indirectly acquires equity securities in a listed Swiss company that exceed 33.33% of the voting rights.
Roche said on Thursday, when the Novartis deal was announced, that it will use debt to finance what it called a “disentanglement of two competitors” and plans to reduce its capital by cancelling the repurchased shares to regain full strategic flexibility.
Source: Read Full Article
U.S. July budget deficit down 30% as COVID spending falls, revenues edge up
With Surge in July, U.S. Recovers the Jobs Lost in the Pandemic
Cambria hotel breaks ground along Brighton in Denvers RiNo neighborhood
U.S. considers crackdown on memory chip makers in China
The city of Aurora has a new vision for the Havana Street corridor and wants to make travel easier for everyone